Despite the predominance of studies demonstrating pronounced anti-inflammatory and antiproliferative effects of PI3K/AKT/mTOR inhibitors in RA-FLS models, the literature persistently retains a stratum of research documenting “null” or contradictory outcomes, which necessitates systematic reflection in light of the data presented herein. Here, MTOR is linked to rheumatoid arthritis.